| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $5,149,388 | 10 | 100 |
| Dayno Jeffrey M. | PRESIDENT, CEO | 0 | $0 | 1 | $237,957 | $-237,957 |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | 0 | $0 | 4 | $1.8M | $-1.8M |
| Budur Kumar | CHIEF MEDICAL OFFICER | 0 | $0 | 5 | $3.11M | $-3.11M |
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out …
Over the last 12 months, insiders at Harmony Biosciences Holdings, Inc. have bought $0 and sold $5.15M worth of Harmony Biosciences Holdings, Inc. stock.
On average, over the past 5 years, insiders at Harmony Biosciences Holdings, Inc. have bought $0 and sold $87.59M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,844 shares for transaction amount of $269,049 was made by Nielsen Jack (director) on 2020‑08‑26.
| 2026-09-18 | Sale | Budur Kumar | CHIEF MEDICAL OFFICER | 35,852 0.0635% | $43.05 | $1.54M | -7.83% | |
| 2026-09-17 | Sale | Budur Kumar | CHIEF MEDICAL OFFICER | 800 0.0014% | $43.00 | $34,400 | -9.31% | |
| 2026-09-16 | Sale | Budur Kumar | CHIEF MEDICAL OFFICER | 1,800 0.0032% | $43.01 | $77,426 | -7.58% | |
| 2026-09-08 | Sale | Budur Kumar | CHIEF MEDICAL OFFICER | 28,454 0.0502% | $42.96 | $1.22M | -6.47% | |
| 2026-09-04 | Sale | Budur Kumar | CHIEF MEDICAL OFFICER | 5,500 0.0094% | $41.98 | $230,911 | -6.84% | |
| 2026-01-26 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 3,746 0.0065% | $37.15 | $139,171 | -5.06% | |
| 2026-01-15 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 20,961 0.0359% | $35.92 | $752,833 | -2.22% | |
| 2025-12-12 | Sale | Dayno Jeffrey M. | PRESIDENT, CEO | 5,933 0.0102% | $40.11 | $237,957 | -11.06% | |
| 2025-12-05 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 20,000 0.0345% | $39.54 | $790,896 | -9.18% | |
| 2025-11-21 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 3,427 0.0061% | $35.00 | $119,945 | +5.04% | |
| 2025-08-15 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 21,573 0.0371% | $36.50 | $787,378 | -9.10% | |
| 2025-04-01 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 6,987 0.0122% | $32.54 | $227,386 | +4.87% | |
| 2025-03-03 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 4,869 0.0086% | $32.67 | $159,090 | +6.25% | |
| 2025-01-27 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 1,775 0.0031% | $38.05 | $67,547 | -10.48% | |
| 2025-01-27 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 1,629 0.0029% | $38.02 | $61,941 | -10.48% | |
| 2025-01-24 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 13,125 0.0227% | $37.31 | $489,634 | -9.93% | |
| 2025-01-21 | Sale | Kapadia Sandip | CHIEF FINANCIAL OFFICER | 25,000 0.0435% | $40.18 | $1M | -15.37% | |
| 2025-01-21 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 1,123 0.0019% | $40.00 | $44,920 | -15.37% | |
| 2025-01-21 | Sale | Dayno Jeffrey M. | PRESIDENT, CEO | 19,293 0.0335% | $40.13 | $774,245 | -15.37% | |
| 2025-01-16 | Sale | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | 29,475 0.0506% | $37.41 | $1.1M | -11.16% |
| Marshman Fund Trust II | 10 percent owner | 6051120 10.3906% | $224.01M | 1 | 2 | <0.0001% |
| Novo Holdings A/S | 10 percent owner | 4409803 7.5722% | $163.25M | 1 | 0 | <0.0001% |
| Nielsen Jack | director | 2571024 4.4148% | $95.18M | 5 | 30 | <0.0001% |
$607,395,062 | 99 | 4.23% | $1.88B | |
$21,345,882 | 83 | 94.45% | $2.19B | |
$47,419,530 | 58 | 17.20% | $1.96B | |
$1,376,668 | 53 | 18.46% | $2.1B | |
$108,353,116 | 49 | 15.41% | $2.17B |
| Increased Positions | 179 | +57.19% | 8M | +16.03% |
| Decreased Positions | 139 | -44.41% | 5M | -9.98% |
| New Positions | 55 | New | 2M | New |
| Sold Out Positions | 30 | Sold Out | 367,652 | Sold Out |
| Total Postitions | 353 | +12.78% | 50M | +6.05% |
| Blackrock, Inc. | $258,892.00 | 11.94% | 6.93M | +189,003 | +2.81% | 2025-09-30 |
| Vanguard Group Inc | $190,532.00 | 8.79% | 5.1M | -13,604 | -0.27% | 2025-09-30 |
| Fmr Llc | $143,800.00 | 6.63% | 3.85M | -841,220 | -17.94% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $63,231.00 | 2.92% | 1.69M | +109,405 | +6.92% | 2025-09-30 |
| American Century Companies Inc | $62,408.00 | 2.88% | 1.67M | +168,145 | +11.2% | 2025-09-30 |
| State Street Corp | $61,812.00 | 2.85% | 1.65M | +24,358 | +1.5% | 2025-09-30 |
| Lsv Asset Management | $59,617.00 | 2.75% | 1.59M | +106,391 | +7.15% | 2025-09-30 |
| Arrowstreet Capital, Limited Partnership | $48,421.00 | 2.23% | 1.3M | +388,472 | +42.84% | 2025-09-30 |
| Valor Management Llc | $47,405.00 | 2.19% | 1.27M | -5M | -80.84% | 2025-09-30 |
| Geode Capital Management, Llc | $47,034.00 | 2.17% | 1.26M | +203,915 | +19.34% | 2025-09-30 |